Results 131 to 140 of about 37,401 (251)

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 14, Page 4022-4047, July 2026.
Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller   +3 more
wiley   +1 more source

Approach With Caution: A Pilot Randomised Controlled Trial of Approach Bias Modification for People Undergoing Residential Treatment for Methamphetamine Use Disorder. [PDF]

open access: yesDrug Alcohol Rev
Manning V   +9 more
europepmc   +1 more source

Patch Test Results With the European Baseline Series, 2021/2022—Joint European Results of the ESSCAA and the EBSB Working Groups of the ESCD, and the GEIDACC

open access: yesContact Dermatitis, Volume 95, Issue 1, Page 17-32, July 2026.
ABSTRACT Background Patch test results obtained with the European Baseline Series (EBS) in its current version serve both contact allergy surveillance and (re‐)assessing the diagnostic value of EBS allergens. Objectives To present results of current EBS patch testing, obtained in 59 departments in 14 European countries during 2021 and 2022.
Wolfgang Uter   +73 more
wiley   +1 more source

Health, Social and Recidivism Outcomes Among People Who Have Been Incarcerated in New South Wales, Australia: Study Protocol and Cohort Profile for the Prison Outcomes STudy (POST)

open access: yesDrug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction We have been funded to examine post‐incarceration health and social outcomes for all people incarcerated in New South Wales, Australia, 2000–2022; assess treatment and services for drug dependence and serious mental illness; and project the impact of expanding intervention coverage. We will use a linked cohort, the Prison Outcomes
Louisa Degenhardt   +19 more
wiley   +1 more source

Qualitative interviews of patients with methamphetamine-associated pulmonary hypertension: Understanding the unmet medical need from the patient lens. [PDF]

open access: yesJHLT Open
Melendres-Groves L   +9 more
europepmc   +1 more source

Adapting ‘The Grog App’ to Ask Aboriginal and Torres Strait Islander Peoples About Their Drinking in Primary Healthcare: A Delphi Study

open access: yesDrug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction Alcohol screening in primary healthcare services, including Aboriginal Community Controlled Health Organisations, may encounter barriers. These include time constraints, competing health priorities and sensitivities about the topic. Digital tools like the Grog App, validated in population settings, offer potential opportunities to
Mustafa Al Ansari   +14 more
wiley   +1 more source

Prevalence and Correlates of Reporting a Gabapentin Prescription for Pain Among People Who Use Opioids: A Longitudinal Community‐Recruited Study

open access: yesDrug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction Gabapentin is widely prescribed off‐label to treat pain. However, there are concerns about the proliferation of medical and non‐medical use, and the potential increased risk of overdose death associated with concurrent opioid use.
Evelyne Marie Piret   +7 more
wiley   +1 more source

Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial.

open access: yesJAMA Psychiatry
McKetin R   +42 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy